November 17, 2016 / 1:27 PM / 9 months ago

BRIEF-Resverlogix says announces successful phase 1 renal trial results

Nov 17 (Reuters) - Resverlogix Corp

* Resverlogix - plans to initiate a phase 2 renal impairment trial that is expected to commence in early 2017 based on pk data confirmed in phase 1 trial

* Resverlogix announces successful phase 1 renal trial results: clears path for future phase 2 studies Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below